Recent FDA warning of the concomitant use of aspirin and ibuprofen and the effects on platelet aggregation.
Ellison
Jason
J
Dager
William
W
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000592:standards; D001241:Aspirin / Q000494:pharmacology* / Q000592:standards; D051545:Cyclooxygenase 1 / Q000187:drug effects; D051546:Cyclooxygenase 2 / Q000187:drug effects; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000592:standards; D004347:Drug Interactions; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology* / Q000592:standards; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000592:standards; D013928:Thromboxane A2 / Q000097:blood; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D010975:Platelet Aggregation Inhibitors; D013928:Thromboxane A2; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D001241:Aspirin; D007052:Ibuprofen